Cascade Investment Advisors Inc. purchased a new position in Metlife Inc (NYSE:MET) during the fourth quarter, Holdings Channel reports. The fund purchased 18,758 shares of the financial services provider’s stock, valued at approximately $948,000.

A number of other hedge funds and other institutional investors have also bought and sold shares of MET. Farmers National Bank purchased a new stake in shares of Metlife during the 2nd quarter worth approximately $118,000. Ffcm LLC raised its holdings in shares of Metlife by 2,020.8% during the 3rd quarter. Ffcm LLC now owns 2,248 shares of the financial services provider’s stock worth $119,000 after acquiring an additional 2,142 shares in the last quarter. Cable Hill Partners LLC raised its holdings in shares of Metlife by 246.6% during the 3rd quarter. Cable Hill Partners LLC now owns 2,412 shares of the financial services provider’s stock worth $125,000 after acquiring an additional 1,716 shares in the last quarter. Valeo Financial Advisors LLC purchased a new stake in shares of Metlife during the 3rd quarter worth approximately $151,000. Finally, Fieldpoint Private Securities LLC purchased a new stake in shares of Metlife during the 3rd quarter worth approximately $175,000. 76.27% of the stock is currently owned by institutional investors.

Several analysts have recently issued reports on the company. Royal Bank of Canada reaffirmed an “outperform” rating and set a $60.00 price objective (up from $56.00) on shares of Metlife in a report on Friday, November 3rd. Morgan Stanley upped their price objective on Metlife from $55.00 to $56.00 and gave the stock an “equal weight” rating in a report on Friday, November 3rd. Argus upped their price objective on Metlife from $55.00 to $60.00 and gave the stock a “buy” rating in a report on Monday, November 6th. Zacks Investment Research raised Metlife from a “strong sell” rating to a “hold” rating in a report on Monday, October 9th. Finally, FBR & Co downgraded Metlife from a “buy” rating to a “neutral” rating and cut their target price for the company from $53.00 to $52.00 in a research report on Tuesday, October 10th. Two analysts have rated the stock with a sell rating, ten have given a hold rating, eight have given a buy rating and one has issued a strong buy rating to the stock. The stock has a consensus rating of “Hold” and an average price target of $57.90.

Metlife Inc (NYSE:MET) opened at $52.55 on Thursday. The firm has a market capitalization of $55,300.00, a P/E ratio of 114.24, a PEG ratio of 1.20 and a beta of 1.49. The company has a current ratio of 0.16, a quick ratio of 0.16 and a debt-to-equity ratio of 0.31. Metlife Inc has a 12-month low of $44.26 and a 12-month high of $55.91.

Metlife (NYSE:MET) last released its earnings results on Wednesday, November 1st. The financial services provider reported $1.09 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.90 by $0.19. The firm had revenue of $16.10 billion for the quarter, compared to the consensus estimate of $15.47 billion. Metlife had a positive return on equity of 8.81% and a negative net margin of 0.75%. The company’s revenue for the quarter was up 1.7% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.28 EPS. analysts forecast that Metlife Inc will post 4.4 earnings per share for the current year.

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 13th. Shareholders of record on Monday, February 5th will be given a $0.40 dividend. This represents a $1.60 annualized dividend and a yield of 3.04%. The ex-dividend date is Friday, February 2nd. Metlife’s dividend payout ratio (DPR) is presently 347.83%.

In other Metlife news, insider Christopher G. Townsend sold 55,712 shares of the company’s stock in a transaction on Monday, November 6th. The stock was sold at an average price of $54.29, for a total value of $3,024,604.48. Following the transaction, the insider now owns 25,181 shares of the company’s stock, valued at approximately $1,367,076.49. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Christopher G. Townsend sold 82,731 shares of the company’s stock in a transaction on Friday, November 3rd. The shares were sold at an average price of $54.60, for a total value of $4,517,112.60. Following the completion of the transaction, the insider now directly owns 49,660 shares in the company, valued at approximately $2,711,436. The disclosure for this sale can be found here. Corporate insiders own 0.32% of the company’s stock.

TRADEMARK VIOLATION NOTICE: This story was reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this story on another site, it was illegally stolen and reposted in violation of US & international copyright and trademark legislation. The original version of this story can be read at https://www.thecerbatgem.com/2018/01/18/cascade-investment-advisors-inc-purchases-shares-of-18758-metlife-inc-met.html.

About Metlife

MetLife, Inc is a provider of life insurance, annuities, employee benefits and asset management. The Company’s segments include U.S.; Asia; Latin America; Europe, the Middle East and Africa (EMEA); MetLife Holdings, and Corporate & Other. Its U.S. segment is organized into Group Benefits, Retirement and Income Solutions and Property & Casualty businesses.

Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Metlife Inc (NYSE:MET).

Institutional Ownership by Quarter for Metlife (NYSE:MET)

Receive News & Ratings for Metlife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Metlife and related companies with MarketBeat.com's FREE daily email newsletter.